Table 3.
Vaccine Platform | Advantage | Disadvantage |
---|---|---|
Inactivated virus |
|
|
Protein subunit |
|
|
mRNA |
|
|
Recombinant viral vector |
|
|
Vaccine Platform | Advantage | Disadvantage |
---|---|---|
Inactivated virus |
|
|
Protein subunit |
|
|
mRNA |
|
|
Recombinant viral vector |
|
|